Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade

(2013) Jennifer Vandooren et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans

(2013) Glen C Jickling et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

All’s well that transcribes well: Non-coding RNAs and post-stroke brain damage

(2013) Raghu Vemuganti   NEUROCHEMISTRY INTERNATIONAL

MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3

(2012) Xuguang Zheng et al.   CANCER LETTERS

Treatment with Evasin-3 Reduces Atherosclerotic Vulnerability for Ischemic Stroke, but Not Brain Injury in Mice

(2012) Jean-Christophe Copin et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse

(2011) Jean-Christophe Copin et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Impact of Tissue Plasminogen Activator on the Neurovascular Unit: From Clinical Data to Experimental Evidence

(2011) Denis Vivien et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity

(2010) Keith Brew et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Inflammatory mechanisms in ischemic stroke: role of inflammatory cells

(2010) Rong Jin et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review

(2010) Maria Ramos-Fernandez et al.   Journal of Stroke & Cerebrovascular Diseases

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside

(2010) MingMing Ning et al.   Translational Stroke Research

Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics

(2009) David Rodríguez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia

(2009) Carme Gubern et al.   BMC MOLECULAR BIOLOGY

Expression of MMP-12 after Neonatal Hypoxic-Ischemic Brain Injury in Mice

(2009) Pernilla Svedin et al.   DEVELOPMENTAL NEUROSCIENCE

Vascular MMP-9/TIMP-2 and Neuronal MMP-10 Up-Regulation in Human Brain after Stroke: A Combined Laser Microdissection and Protein Array Study

(2009) Eloy Cuadrado et al.   JOURNAL OF PROTEOME RESEARCH

Matrix metalloproteinase 12 silencing: A therapeutic approach to treat pathological lung tissue remodeling?

(2009) Nancy Garbacki et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats

(2008) Jean-Christophe Copin et al.   EXPERIMENTAL NEUROLOGY

Matrix Metalloproteinase-13 is Activated and is found in the Nucleus of Neural Cells after Cerebral Ischemia

(2008) Eloy Cuadrado et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Tissue Inhibitor of Metalloproteinases Protect Blood—Brain Barrier Disruption in Focal Cerebral Ischemia

(2008) Motoaki Fujimoto et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The regulation of matrix metalloproteinases and their inhibitors

(2007) I CLARK et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY